Search clinical trials for: Lenalidomide (Revlimid®)
Total 14693 results
-
CelgeneCompletedLymphoma, Non-HodgkinUnited States, Spain, China, Belgium, France, United Kingdom, Israel, Turkey, Russian Federation, Italy, Brazil, Czechia, Portugal, Germany, Japan, Poland, Puerto Rico
-
The Lymphoma Academic Research OrganisationCentre Henri BecquerelCompletedDiffuse Large B Cell LymphomaFrance, Belgium
-
M.D. Anderson Cancer CenterCelgene; Onyx Therapeutics, Inc.Terminated
-
Georgetown UniversityCelgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
OncotherapeuticsCelgene CorporationCompletedMultiple MyelomaUnited States
-
Gesellschaft fur Medizinische Innovation - Hamatologie...ClinAssess GmbHCompletedMultiple MyelomaGermany
-
M.D. Anderson Cancer CenterDaiichi SankyoRecruiting
-
Northwestern UniversityNational Cancer Institute (NCI); CelgeneActive, not recruitingPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Stage III Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous... and other conditionsUnited States
-
University of ChicagoActive, not recruitingMultiple MyelomaUnited States, Poland
-
CelgeneCompletedB-Cell Chronic Lymphocytic LeukemiaUnited States, Spain, Australia, Belgium, Italy, Serbia, Poland, Israel, New Zealand, Portugal, Brazil, France, Bulgaria, Croatia, Czechia, Hungary, Russian Federation, Netherlands, Romania, Denmark, United Kingdom, Austria, Canada, South... and more
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedHematologic DisorderUnited States
-
Bionor Immuno ASCelgene CorporationCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Celgene CorporationCompletedAllogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete RemissionMultiple MyelomaUnited States
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
New Mexico Cancer Care AllianceCelgene CorporationTerminatedOvarian Cancer | Epithelial Ovarian Cancer | Fallopian Tube Carcinoma | Primary Peritoneal CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Celgene CorporationActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
University of LeedsTakeda; Cancer Research UK; CelgeneRecruitingMultiple MyelomaUnited Kingdom
-
Columbia UniversityCelgene CorporationCompletedProstate CancerUnited States
-
Washington University School of MedicineCelgene CorporationCompleted
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
Cancer Trials IrelandCompleted
-
Georgetown UniversityCelgene Corporation; CephalonCompletedNon-Hodgkin's Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
Hackensack Meridian HealthCelgene CorporationTerminatedSmall Lymphocytic Lymphoma | Chronic Lymphocytic Leukemia(CLL)United States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
University Health Network, TorontoCompletedMultiple Myeloma | Renal FailureCanada
-
Technische Universität DresdenCelgene CorporationTerminatedMyelodysplastic Syndromes | Acute Myelogenous LeukemiaGermany
-
SanofiCompletedPlasma Cell MyelomaUnited States
-
AbbVieGenentech, Inc.; Celgene CorporationWithdrawnMultiple MyelomaUnited States, Australia, Canada, Spain
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)TerminatedIntraocular Melanoma | Malignant Conjunctival NeoplasmUnited States
-
Emory UniversityCelgene CorporationTerminatedLeukemia, Lymphocytic, Chronic, B-Cell | Chronic Lymphocytic Leukemia | Lymphoma, Small LymphocyticUnited States
-
Peter MacCallum Cancer Centre, AustraliaRecruitingFollicular LymphomaUnited States, Australia
-
Mikkael Sekeres, MDBristol-Myers Squibb; CelgeneRecruitingMyelodysplastic SyndromesUnited States
-
Cristina GasparettoCelgene CorporationCompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Recurrent B-Cell Prolymphocytic Leukemia | Refractory B-Cell Prolymphocytic LeukemiaUnited States
-
Ruijin HospitalActive, not recruitingDiffuse Large B Cell LymphomaChina
-
Joaquín Martínez López, MD, PhDHospital Infantil Universitario Niño Jesús, Madrid, SpainCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFatigue | Thrombocytopenia | Fever | Chronic Lymphocytic Leukemia | Lymphadenopathy | Small Lymphocytic Lymphoma | Hypogammaglobulinemia | Lymphocytosis | Night Sweats | ParaproteinemiaUnited States
-
Seagen Inc.Genentech, Inc.CompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
OncotherapeuticsTakedaTerminatedNewly Diagnosed Multiple MyelomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedAnemia | Chronic Myelomonocytic Leukemia | Adult Myelodysplastic SyndromeUnited States
-
TG Therapeutics, Inc.James P. Wilmot Cancer CenterTerminatedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States
-
CelgeneTerminatedRenal Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Celgene CorporationCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene Corporation; Ortho Biotech Clinical Affairs, L.L.C.CompletedMultiple MyelomaUnited States
-
Bristol-Myers SquibbAbbVieActive, not recruitingMultiple MyelomaUnited States, Canada, Australia, Poland, Italy, Belgium, Spain, Japan, Greece, Hungary, Romania, Turkey, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Light Chain Deposition DiseaseUnited States, Puerto Rico, Ireland
-
M.D. Anderson Cancer CenterActive, not recruitingSmoldering Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminated